Renal Cell Carcinoma (Record no. 96172)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03787nam a22004815i 4500 |
001 - CONTROL NUMBER | |
control field | 978-1-62703-062-5 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20140220082834.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 120925s2013 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781627030625 |
-- | 978-1-62703-062-5 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/978-1-62703-062-5 |
Source of number or code | doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC870-923.2 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC875-899.5 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MJS |
Source | bicssc |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED088000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.6 |
Edition number | 23 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Campbell, Steven C. |
Relator term | editor. |
245 10 - TITLE STATEMENT | |
Title | Renal Cell Carcinoma |
Medium | [electronic resource] : |
Remainder of title | Clinical Management / |
Statement of responsibility, etc | edited by Steven C. Campbell, Brian I. Rini. |
264 #1 - | |
-- | Totowa, NJ : |
-- | Humana Press : |
-- | Imprint: Humana Press, |
-- | 2013. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | XI, 362 p. 91 illus., 46 illus. in color. |
Other physical details | online resource. |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
347 ## - | |
-- | text file |
-- | |
-- | rda |
490 1# - SERIES STATEMENT | |
Series statement | Current Clinical Urology |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Section I: Localized Disease -- 1.Etiology of RCC: Incidence, Demographics, and Environmental Factors -- 2.Pathology of Renal Cell Carcinoma -- 3.Familial Renal Cell Carinoma -- 4.Imaging of Renal Cell Carcinoma -- 5.Prognostic Factors for Localized Renal Cell Carcinoma -- Section II: Management of Localized RCC -- 6.Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass Biopsy -- 7.Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations -- 8.Nephron-Sparing Surgery for Renal Cancer -- 9.Thermal Ablation -- 10.Active Surveillance of the Small Renal Mass -- Section III: Locally Advanced Disease -- 11.Locally Advanced Renal Cell Carcinoma -- 12.Neoadjuvant Targeted Therapy and Consolidative Surgery -- Section IV: Advanced Disease -- 13.Biology of RCC (VEGF, mTOR, immune aspects) -- 14.Prognostic Factors in Advanced Renal Cell Carcinoma -- 5.Integration of Surgery in Metastatic Renal Cancer -- 16.Immunotherapy for Renal Cell Carcinoma -- 17.Targeted Therapy: Vascular Endothelial Growth Factor (VEGF) -- 18.mTOR in Renal cell carcinoma -- 19.Palliative and Supportive Care for Renal Cancer. |
520 ## - SUMMARY, ETC. | |
Summary, etc | Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Oncology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Urology. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Medicine & Public Health. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Urology/Andrology. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Oncology. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rini, Brian I. |
Relator term | editor. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY | |
Title | Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Display text | Printed edition: |
International Standard Book Number | 9781627030618 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Current Clinical Urology |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-62703-062-5 |
912 ## - | |
-- | ZDB-2-SME |
No items available.